Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Tax Provisions: 2023-2025

Historic Tax Provisions for Arcutis Biotherapeutics (ARQT) over the last 1 years, with Sep 2025 value amounting to $80,000.

  • Arcutis Biotherapeutics' Tax Provisions was N/A to $80,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year change of. This contributed to the annual value of $647,000 for FY2024, which is 79.22% down from last year.
  • According to the latest figures from Q3 2025, Arcutis Biotherapeutics' Tax Provisions is $80,000, which was down 76.61% from $342,000 recorded in Q2 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Tax Provisions registered a high of $3.0 million during Q3 2023, and its lowest value of $25,000 during Q4 2023.
  • Moreover, its 3-year median value for Tax Provisions was $323,000 (2024), whereas its average is $628,000.
  • In the last 5 years, Arcutis Biotherapeutics' Tax Provisions surged by 1,192.00% in 2024 and then declined by 13.89% in 2025.
  • Quarterly analysis of 3 years shows Arcutis Biotherapeutics' Tax Provisions stood at $25,000 in 2023, then surged by 1,192.00% to $323,000 in 2024, then declined by 13.89% to $80,000 in 2025.
  • Its last three reported values are $80,000 in Q3 2025, $342,000 for Q2 2025, and $279,000 during Q1 2025.